GLP-1 Pill Cut Heart Failure Events in Some Diabetes Patients

By News Health
34 minutes Ago

(MedPage Today) — Oral semaglutide (Rybelsus) protected against heart failure events in type 2 diabetes patients with a history of heart failure and either atherosclerotic cardiovascular disease, chronic kidney disease, or both, according to findings…

Source link : https://www.medpagetoday.com/cardiology/chf/119701

Author :

Publish date : 2026-02-02 21:48:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Time of Day Matters for Immunochemotherapy in Lung Cancer

Researchers Parse Heart Risks in Hypertensive Disorders of Pregnancy

New Emphasis on N1 Lymph Nodes Dawns on Lung Resections

Celebrity Doctor Interacted With Jeffrey Epstein

Thymectomy in Myasthenia Gravis: Who Benefits?

Identifying the Signs of Myasthenia Gravis